Literature DB >> 25211390

Enhancement of α5-containing γ-aminobutyric acid type A receptors by the nonimmobilizer 1,2-dichlorohexafluorocyclobutane (F6) is abolished by the β3(N265M) mutation.

Paul M Burkat1, Chong Lor, Misha Perouansky, Robert A Pearce.   

Abstract

BACKGROUND: Modulation of γ-aminobutyric acid type A receptors (GABAARs) by general anesthetics may contribute to their ability to produce amnesia. Receptors containing α5 subunits, which mediate tonic and slow synaptic inhibition, are co-localized with β3 and γ2 subunits in dendritic layers of the hippocampus and are sensitive to low (amnestic) concentrations of anesthetics. Because α5 and β3 subunits influence performance in hippocampus-dependent learning tasks in the presence and absence of general anesthetics, and the experimental inhaled drug 1,2-dichlorohexafluorocyclobutane (F6) impairs hippocampus-dependent learning, we hypothesized that F6 would modulate receptors that incorporate α5 and β3 subunits. We hypothesized further that the β3(N265M) mutation, which controls receptor modulation by general anesthetics, would similarly influence modulation by F6.
METHODS: Using whole-cell electrophysiologic recording techniques, we tested the effects of F6 at concentrations ranging from 4 to 16 μM on receptors expressed in human embryonic kidney 293 cells. We measured drug modulation of wild-type α5β3 and α5β3γ2L GABAARs and receptors harboring the β3(N265M) mutation. We also tested the effects of F6 on α1β2γ2L receptors, which were reported previously to be insensitive to this drug when expressed in Xenopus oocytes.
RESULTS: F6 enhanced the responses of wild-type α5β3γ2L but not α1β2γ2L receptors to low concentrations of GABA in a concentration-dependent manner. Receptors that incorporated the mutant β3(N265M) subunit were insensitive to F6. When applied together with a high concentration of GABA, F6 blocked currents through α5β3 but not α5β3γ2L receptors. F6 did not alter deactivation of α5β3γ2L receptors after brief high- concentration pulses of GABA.
CONCLUSIONS: The nonimmobilizer F6 modulates GABAARs in a manner that depends on subunit composition and mode of receptor activation by GABA, supporting a possible role for α5-containing receptors in suppression of learning and memory by F6. Furthermore, common structural requirements indicate that similar molecular mechanisms may be responsible for the enhancing effects of F6 and conventional general anesthetics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25211390      PMCID: PMC4237654          DOI: 10.1213/ANE.0000000000000423

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  44 in total

1.  GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.

Authors:  S Pirker; C Schwarzer; A Wieselthaler; W Sieghart; G Sperk
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Molecular determinants for the action of general anesthetics at recombinant alpha(2)beta(3)gamma(2)gamma-aminobutyric acid(A) receptors.

Authors:  Roberta Siegwart; Rachel Jurd; Uwe Rudolph
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

3.  Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor.

Authors:  Neil Collinson; Frederick M Kuenzi; Wolfgang Jarolimek; Karen A Maubach; Rosa Cothliff; Cyrille Sur; Alison Smith; Franklin M Otu; Owain Howell; John R Atack; Ruth M McKernan; Guy R Seabrook; Gerry R Dawson; Paul J Whiting; Thomas W Rosahl
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

4.  Anesthetic-induced immobility: neuronal nicotinic acetylcholine receptors are no longer in the picture.

Authors:  Cecilia M Borghese; R Adron Harris
Journal:  Anesth Analg       Date:  2002-09       Impact factor: 5.108

5.  Evidence for a common binding cavity for three general anesthetics within the GABAA receptor.

Authors:  A Jenkins; E P Greenblatt; H J Faulkner; E Bertaccini; A Light; A Lin; A Andreasen; A Viner; J R Trudell; N L Harrison
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

6.  Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with [³H]TDBzl-etomidate, a photoreactive etomidate analogue.

Authors:  David C Chiara; Zuzana Dostalova; Selwyn S Jayakar; Xiaojuan Zhou; Keith W Miller; Jonathan B Cohen
Journal:  Biochemistry       Date:  2012-01-23       Impact factor: 3.162

7.  The gamma subunit determines whether anesthetic-induced leftward shift is altered by a mutation at alpha1S270 in alpha1beta2gamma2L GABA(A) receptors.

Authors:  M Scheller; S A Forman
Journal:  Anesthesiology       Date:  2001-07       Impact factor: 7.892

8.  Agonist gating and isoflurane potentiation in the human gamma-aminobutyric acid type A receptor determined by the volume of a second transmembrane domain residue.

Authors:  V V Koltchine; S E Finn; A Jenkins; N Nikolaeva; A Lin; N L Harrison
Journal:  Mol Pharmacol       Date:  1999-11       Impact factor: 4.436

9.  Short-term memory resists the depressant effect of the nonimmobilizer 1-2-dichlorohexafluorocyclobutane (2N) more than long-term memory.

Authors:  Robert C Dutton; Anya J Maurer; James M Sonner; Michael S Fanselow; Michael J Laster; Edmond I Eger
Journal:  Anesth Analg       Date:  2002-03       Impact factor: 5.108

10.  Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors.

Authors:  F Crestani; R Keist; J-M Fritschy; D Benke; K Vogt; L Prut; H Blüthmann; H Möhler; U Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more
  2 in total

Review 1.  Recent progress on the molecular pharmacology of propofol.

Authors:  Pei Tang; Roderic Eckenhoff
Journal:  F1000Res       Date:  2018-01-29

2.  Isoflurane Potentiation of GABAA Receptors Is Reduced but Not Eliminated by the β3(N265M) Mutation.

Authors:  Chong Lor; Misha Perouansky; Robert A Pearce
Journal:  Int J Mol Sci       Date:  2020-12-15       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.